INCB013739

DRUG2 trials

Sponsors

Incyte Corporation

Conditions

Diabetes Mellitus, Type 2ObesityType 2 Diabetes

Phase 2

Pharmacodynamic Study of the Effect of INCB013739 on Insulin Sensitivity in Obese, Type 2 Diabetic Subjects

CompletedNCT00478322

Incyte CorporationDiabetes Mellitus, Type 2, Obesity

Start: 2007-04-30End: 2008-02-29Updated: 2016-12-06

Safety and Efficacy of INCB013739 Plus Metformin Compared to Metformin Alone on Glycemic Control in Type 2 Diabetics

CompletedNCT00698230

Incyte CorporationType 2 Diabetes

Start: 2008-05-31End: 2009-05-31Updated: 2018-02-14